ADA Says All Diabetes Patients Should Be Screened for Nonalcoholic ... - STAT
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
PubMed • GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Statins Slash GLP-1 Levels - Human Controlled Trial
(đź”— at the end)
1/9) Usually, scientific research excites me. But the paper I just read? It both excited and annoyed me.
It explores how statins – the most profitable drug in history, with annual sales exceeding $20 billion – contribute to... See more
This Clinical Insights discusses new diagnostic criteria, risk stratification, and emerging treatments of metabolic dysfunction–associated steatotic liver disease.
https://t.co/iU8H6egzoB https://t.co/HNykARqJBX